semaglutide phase 2 Novo Nordisk announced headline results from STEP UP, a IIIb trial investigating subcutaneous 7.2 mg for obesity PDF] A Phase 2, Randomized,
Pay in 4 interest-free payments of $6.38 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 24 - Oct 29
![semaglutide phase 2 Novo Nordisk announced headline results from STEP UP, a IIIb trial investigating subcutaneous 7.2 mg for obesity PDF] A Phase 2, Randomized,](https://ai2-s2-public.s3.amazonaws.com/figures/2017-08-08/7c7543416a247a5a34e98769da2d20a023a4651c/6-Figure2-1.png)
![semaglutide phase 2 Novo Nordisk announced headline results from STEP UP, a IIIb trial investigating subcutaneous 7.2 mg for obesity PDF] A Phase 2, Randomized,](https://pro.novonordisk.ae/content/dam/hcp-plus/ae/en/scientific-hub/novo-nordisk-medical-education/essence-trial-overview-and-part-1-results/images/essence-trial-overview-and-part-1-results-treatmwnts-in-mash.png)
![semaglutide phase 2 Novo Nordisk announced headline results from STEP UP, a IIIb trial investigating subcutaneous 7.2 mg for obesity PDF] A Phase 2, Randomized,](https://www.nejm.org/cms/10.1056/NEJMoa2028395/asset/7c4be93e-d7c7-4d0d-bf18-52de90591a13/assets/images/large/nejmoa2028395_f1.jpg)




















